These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 17068285)
1. Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. van Wanrooij EJ; van Puijvelde GH; de Vos P; Yagita H; van Berkel TJ; Kuiper J Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):204-10. PubMed ID: 17068285 [TBL] [Abstract][Full Text] [Related]
2. Interruption of the OX40-OX40 ligand pathway in LDL receptor-deficient mice causes regression of atherosclerosis. Foks AC; van Puijvelde GH; Bot I; ter Borg MN; Habets KL; Johnson JL; Yagita H; van Berkel TJ; Kuiper J J Immunol; 2013 Nov; 191(9):4573-80. PubMed ID: 24068673 [TBL] [Abstract][Full Text] [Related]
3. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells. Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577 [TBL] [Abstract][Full Text] [Related]
4. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis. Yoshioka T; Nakajima A; Akiba H; Ishiwata T; Asano G; Yoshino S; Yagita H; Okumura K Eur J Immunol; 2000 Oct; 30(10):2815-23. PubMed ID: 11069062 [TBL] [Abstract][Full Text] [Related]
5. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40. Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):657-63. PubMed ID: 16431965 [TBL] [Abstract][Full Text] [Related]
6. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology. Ishii N; Takahashi T; Soroosh P; Sugamura K Adv Immunol; 2010; 105():63-98. PubMed ID: 20510730 [TBL] [Abstract][Full Text] [Related]
8. OX40-OX40 ligand interaction may activate phospholipase C signal transduction pathway in human umbilical vein endothelial cells. Yan J; Wang C; Du R; Liu P; Chen G Chem Biol Interact; 2009 Aug; 180(3):460-4. PubMed ID: 19416722 [TBL] [Abstract][Full Text] [Related]
9. Negative regulation of IL-17 production by OX40/OX40L interaction. Li J; Li L; Shang X; Benson J; Merle Elloso M; Schantz A; Bracht M; Orlovsky Y; Sweet R Cell Immunol; 2008; 253(1-2):31-7. PubMed ID: 18501882 [TBL] [Abstract][Full Text] [Related]
10. OX40 (CD134) and OX40 ligand interaction plays an adjuvant role during in vivo Th2 responses. Ishii N; Ndhlovu LC; Murata K; Sato T; Kamanaka M; Sugamura K Eur J Immunol; 2003 Sep; 33(9):2372-81. PubMed ID: 12938213 [TBL] [Abstract][Full Text] [Related]
11. [Effect of the costimulatory molecules OX40-OX40 ligand interaction on the expression of NFATc1 in leukocytes of apolipoprotein E-deficient mice]. Xu LJ; Yan JC; Wang B; Liu PJ; Gong J; Wang CP Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jun; 39(6):526-30. PubMed ID: 21924079 [TBL] [Abstract][Full Text] [Related]
12. OX40 ligand plays an important role in the development of atherosclerosis through vasa vasorum neovascularization. Nakano M; Fukumoto Y; Satoh K; Ito Y; Kagaya Y; Ishii N; Sugamura K; Shimokawa H Cardiovasc Res; 2010 Dec; 88(3):539-46. PubMed ID: 20584752 [TBL] [Abstract][Full Text] [Related]
13. CD40 and OX40 ligand are differentially regulated on asthmatic airway smooth muscle. Krimmer DI; Loseli M; Hughes JM; Oliver BG; Moir LM; Hunt NH; Black JL; Burgess JK Allergy; 2009 Jul; 64(7):1074-82. PubMed ID: 19220210 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of anti-OX40L and anti-TNF-alpha MAbs in a murine model of chronic colitis. Totsuka T; Kanai T; Uraushihara K; Iiyama R; Yamazaki M; Akiba H; Yagita H; Okumura K; Watanabe M Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G595-603. PubMed ID: 12631559 [TBL] [Abstract][Full Text] [Related]
15. Rapid induction of OX40 ligand on primary T cells activated under DNA-damaging conditions. Kondo K; Okuma K; Tanaka R; Matsuzaki G; Ansari AA; Tanaka Y Hum Immunol; 2008 Sep; 69(9):533-42. PubMed ID: 18718855 [TBL] [Abstract][Full Text] [Related]
16. Consequences of OX40-OX40 ligand interactions in langerhans cell function: enhanced contact hypersensitivity responses in OX40L-transgenic mice. Sato T; Ishii N; Murata K; Kikuchi K; Nakagawa S; Ndhlovu LC; Sugamura K Eur J Immunol; 2002 Nov; 32(11):3326-35. PubMed ID: 12555678 [TBL] [Abstract][Full Text] [Related]
17. OX40, OX40L and Autoimmunity: a Comprehensive Review. Webb GJ; Hirschfield GM; Lane PJ Clin Rev Allergy Immunol; 2016 Jun; 50(3):312-32. PubMed ID: 26215166 [TBL] [Abstract][Full Text] [Related]
18. OX40-OX40L interaction promotes proliferation and activation of lymphocytes via NFATc1 in ApoE-deficient mice. Yan J; Su H; Xu L; Wang C PLoS One; 2013; 8(4):e60854. PubMed ID: 23593329 [TBL] [Abstract][Full Text] [Related]
19. Activity of soluble OX40 ligand is enhanced by oligomerization and cell surface immobilization. Müller N; Wyzgol A; Münkel S; Pfizenmaier K; Wajant H FEBS J; 2008 May; 275(9):2296-304. PubMed ID: 18397322 [TBL] [Abstract][Full Text] [Related]
20. Identification of rat OX40 ligand by molecular cloning. Akiba H; Atsuta M; Yagita H; Okumura K Biochem Biophys Res Commun; 1998 Oct; 251(1):131-6. PubMed ID: 9790919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]